KATHERINE WILLIAMSON: Open Payments
NPI 1043673460 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 44 payments from 20 companies in 2025. Trend: 2023 $739 · 2024 $695 · 2025 $960
Food & beverage: $793Education: $167
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Almirall LLC | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $62 |
| Organon LLC | 5 | $55 |
| Amgen Inc. | 3 | $45 |
| Galderma Laboratories, L.P. | 2 | $38 |
Products named: TREMFYA, Klisyri, COSENTYX, DUPIXENT, Zoryve, TALTZ, OTEZLA, VTAMA.
Industry payments across TX — which companies pay providers there.
